Holen Sie sich die Stockscreener-App
0.7359
1.12%
-0.0083
Handel nachbörslich:
.74
0.0041
+0.56%
Schlusskurs vom Vortag:
$0.7442
Offen:
$0.733
24-Stunden-Volumen:
163.24K
Relative Volume:
1.39
Marktkapitalisierung:
$5.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.28M
KGV:
-0.0529
EPS:
-13.91
Netto-Cashflow:
$-13.75M
1W Leistung:
-9.33%
1M Leistung:
-4.53%
6M Leistung:
-37.64%
1J Leistung:
-84.44%
1-Tages-Spanne:
$0.70
$0.7512
1-Wochen-Bereich:
$0.70
$0.83
52-Wochen-Spanne:
$0.65
$4.59
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Firmenname
Pasithea Therapeutics Corp
Sektor
Branche
Telefon
(702) 514-4174
Adresse
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Vergleichen Sie KTTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.7359 | 5.54M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
Chart based exit strategy for Pasithea Therapeutics Corp.Exit Point & Safe Entry Trade Signal Reports - newser.com
Can swing trading help recover from Pasithea Therapeutics Corp. losses2025 Short Interest & Growth Focused Entry Point Reports - newser.com
Institutional scanner results for Pasithea Therapeutics Corp.Market Volume Report & Safe Swing Trade Setups - newser.com
How Pasithea Therapeutics Corp. Equity Warrant stock trades during market volatilityMarket Volume Summary & Weekly High Conviction Ideas - newser.com
Real time breakdown of Pasithea Therapeutics Corp. stock performanceJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com
Multi asset correlation models including Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Reactions & Long-Term Growth Plans - newser.com
How currency fluctuations impact Pasithea Therapeutics Corp. stock2025 Biggest Moves & Verified Entry Point Signals - newser.com
Understanding Pasithea Therapeutics Corp. Equity Warrant’s price movementMarket Activity Recap & Scalable Portfolio Growth Ideas - newser.com
Has Pasithea Therapeutics Corp. Equity Warrant found a price floorJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
How Pasithea Therapeutics Corp. stock responds to policy changesQuarterly Portfolio Review & Low Risk High Win Rate Picks - newser.com
Is Pasithea Therapeutics Corp. stock a dividend growth opportunityWeekly Stock Recap & Growth Focused Entry Reports - newser.com
How Pasithea Therapeutics Corp. stock performs in interest rate cyclesMarket Risk Report & Low Risk High Win Rate Stock Picks - newser.com
Pasithea Therapeutics Corp.’s volatility index tracking explainedJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com
Pasithea Therapeutics Corp. Equity Warrant stock trend forecastInflation Watch & Weekly Stock Breakout Alerts - newser.com
Using flow based indicators on Pasithea Therapeutics Corp.Portfolio Return Report & Low Drawdown Trading Techniques - newser.com
Pasithea Therapeutics Corp Stock Analysis and ForecastStock Buy Signals & Maximize Returns With Insights - earlytimes.in
What risks investors should watch in Pasithea Therapeutics Corp. stockPortfolio Update Summary & Safe Capital Investment Plans - newser.com
Is Pasithea Therapeutics Corp. forming a bottoming baseJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-10 08:53:04 - newser.com
Will a bounce in Pasithea Therapeutics Corp. offer an exitWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Short interest data insights for Pasithea Therapeutics Corp. Equity Warrant2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
Will Pasithea Therapeutics Corp. stock maintain dividend yield2025 Earnings Surprises & Weekly Return Optimization Alerts - newser.com
What moving averages say about Pasithea Therapeutics Corp.2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com
Can Pasithea Therapeutics Corp. stock rebound after recent weakness2025 Trade Ideas & Weekly Momentum Picks - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock deliver strong dividend growthQuarterly Profit Review & Real-Time Stock Entry Alerts - newser.com
Can swing trading help recover from Pasithea Therapeutics Corp. Equity Warrant lossesPortfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Published on: 2025-10-09 02:47:31 - newser.com
Pasithea Therapeutics Corp. stock daily chart insightsQuarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Pasithea Therapeutics Corp Equity Warrant Stock Analysis and ForecastFederal Reserve Announcements & Get Tomorrow’s Winners Today With AI - earlytimes.in
What recovery options are there for Pasithea Therapeutics Corp.Product Launch & Free Community Supported Trade Ideas - newser.com
Is a relief rally coming for Pasithea Therapeutics Corp. Equity Warrant holdersJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com
Is it time to cut losses on Pasithea Therapeutics Corp.July 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Using R and stats models for Pasithea Therapeutics Corp. forecasting2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
Can technical indicators confirm Pasithea Therapeutics Corp. Equity Warrant’s reversalJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Trend analysis for Pasithea Therapeutics Corp. this weekWall Street Watch & Weekly Top Stock Performers List - newser.com
What Makes Three M Paper Boards Limited Stand Out Among CompetitorsVolume Weighted Average Price & Maximum Profit Growth - earlytimes.in
Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pasithea Therapeutics Corp-Aktie (KTTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):